ArticleCold Spring Harbor molecular case studies2021

Potential benefit of treatment with MEK inhibitors and chemotherapy in BRAF-mutated KRAS wild-type pancreatic ductal adenocarcinoma patients: a case report.

Bach Ardalan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.